Myeloid Leukemia Drug Disappoints in Parkinson ' s Disease Myeloid Leukemia Drug Disappoints in Parkinson ' s Disease

Despite showing neuroprotective effects in preclinical models of Parkinson ' s disease, the tyrosine kinase inhibitor nilotinib does not appear to have a future for this condition.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news